Researchers have developed a new way to deliver molecular therapies to cells. The system, called SEND, can be programmed to encapsulate and deliver different RNA cargoes. Learn more: broad.io/SEND

CPCV advisor, Cathy Wu presents #NeoVax vaccines at #SITC2021

For the first time, the U.S. FDA has approved an #immunotherapy drug given after surgery for certain patients with #kidneycancer. The approval of adjuvant pembrolizumab was based on clinical testing led by Dana-Farber's Toni Choueiri, MD (Toni Choueiri, MD): ms.spr.ly/6019k5xyf

Our colleague Toni Choueiri, MD spoke with Scientific American (Scientific American) about the important studies he’s led to understand the pandemic’s impact on cancer screenings and diagnosis. scientificamerican.com/article/the-co…

Today, March 22nd, is #LynchSyndromeAwarenessDay. Know your risk. Dana-Farber's Matt Yurgelun, MD (Matt Yurgelun, MD), explains what #LynchSyndrome is and who should get tested for this genetic condition that increases risk for a variety of cancers 👇

Congratulations to the #NeoVax team! - Neoantigen personal vaccines gets selected as the International Society of Vaccines' 2021 paper of the year! #vaccines #ISV

It has been 75 years of clinical care and cutting edge research Dana-Farber Dana-Farber News Dana-Farber News DF/HCC Dana-Farber’s Breast Oncology Center Dana-Farber Center for Cancer Vaccines Dana-Farber Data Science OncoAlert G O L D I E. Ellen Berlin✌🏼🦞✡️🌍☀️⚾️🇺🇸 Victoria Warren

🎉 Celebrating our co-founder Ed Fritsch excellent review on #cancer #vaccines! Dana-Farber Center for Cancer Vaccines ow.ly/icA450K0fTI

Panelists from the SITC Primer Session featuring Marcela Maus, Cathy Wu, Sangeeta Goswami, and Jennifer Guerriero

Living with kidney cancer: Alan Rubin shares his experience with a clinical trial at Dana-Farber after he was diagnosed with #KidneyCancer. He says his comfort-level and trust in his care team have helped him navigate his treatment. CC: Dana-Farber Lank Center for Genitourinary Oncology

Featured in the @DailyBeast, researchers at Dana-Farber have created an AI-based tool that uses tumor gene sequencing data to predict the primary source of a patient’s cancer. Read more: thedailybeast.com/this-ai-could-…

The Sjöberg Prize 2024 is awarded to Catherine J. Wu 🌟 Catherine J. Wu, of the Dana-Farber Cancer Institute in Boston, USA, is a pioneer in research that may result in the development of personalised vaccines to treat cancer. She is now awarded the Sjöberg Prize, worth one

edition.cnn.com/2024/02/20/hea… #CPCV #NeoVax #PersonalizedMedicine

Successful anti-cancer immune responses reported in phase 1 trial of a personalized cancer vaccine for #kidneycancer. Research in nature led by Toni Choueiri, MD #PatrickOtt #CatherineWu #DerinKeskin (all of Dana-Farber) and David Braun of Yale Cancer Center ➡️ bit.ly/3CDIT3n

1/ JUST IN: an 8 year #kidneycancer journey now published in nature: “A personalized neoantigen vaccine generates anti-tumor immunity in high-risk renal cell carcinoma”. A trial of #RCC vaccine, led together with first author David Braun Yale Cancer Center and #PatrickOtt #DerinKeskin

In STAT: 9 patients w/advanced kidney cancer who received an experimental vaccine tailored to tumors’ specific mutations mounted an immune response and remained cancer-free for three years. Toni Choueiri, MD explains more on the early-phase clinical trial. bit.ly/410HOMm

Nature research paper: A neoantigen vaccine generates antitumour immunity in renal cell carcinoma go.nature.com/4gxKe9T

𝐁𝐫𝐢𝐠𝐡𝐭 𝐌𝐢𝐧𝐝𝐬: Dana-Farber investigators Toni Choueiri, MD and Patrick Ott describe a personalized cancer vaccine trial in kidney cancer that was published in Nature. All nine patients did not see their cancer recur. Full video: biotechtv.com/post/dana-farb…

Featured on WBZ | CBS News Boston: Dana-Farber's Cathy Wu, MD, and Toni Choueiri, MD, explain the science and results of a study looking at making a kidney cancer vaccine personalized to an individual patient's tumor. cbsnews.com/boston/video/b… cc: Toni Choueiri, MD Dana-Farber Lank Center for Genitourinary Oncology

Thank you ACIR for highlighting our nature #personalizedcancervaccine article in #kidneycancer with this nice graphic! acir.org/weekly-digests…